Foundation Medicine Cash Flow - Quarterly (NASDAQ:FMI)

Add to My Stocks
$136.45 $0.3 (0.22%) FMI stock closing price Jun 20, 2018 (Closing)

The financial analysis of FMI requires an investor to check the cash flows for Foundation Medicine. While its important to look at the Foundation Medicine debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Foundation Medicine revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Foundation Medicine saw a cash impact of $3.43M from the issuance of FMI shares. The cash flow statement helps in the Foundation Medicine stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Foundation Medicine had an outflow of $-38.89M from operating activities, $33.43M inflow due to financing activities, and $-5.68M outflow due to investing activities till 2018 Q1.

View and download details of Foundation Medicine cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
-37.41M-161.46M-123.35M-90.71M-46.45M-113.19M-77.58M-46.3M-17.3M-89.63M
Depreciation Depletion Amortization Cash-Flow5.36M18.51M13.5M8.84M4.46M15.94M11.52M7.23M3.06M10.6M
Net Increase (Decrease) in Assets Liabilities-10.05M-0.21M2.68M1.86M-5.93M10.3M2.87M2.45M1.14M3.82M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net3.2M22.17M18.03M13M6.27M19.77M13.74M7.81M3.11M11.48M
Net Cash from (used by) Operating Activities
-38.89M-120.99M-89.13M-67M-41.64M-67.16M-49.43M-28.79M-9.97M-63.72M
Increase (Decrease) in Prop Plant And Equipment-5.68M-15.65M-9.97M-6.7M-3.86M-20.87M-14M-11.99M-7.56M-25.43M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-79.39M79.39M44.39M29.39M33.56M23M-14.99M-14.3M-114.75M
Other Cash Inflow (Outflow) from Investment Activities--0.91M-0.9M-------0.53M
Net Cash from (used by) Investment Activities
-5.68M62.82M68.51M37.68M25.53M12.68M9M-26.98M-21.87M-140.71M
Issuance (Purchase) of Equity Shares3.43M5.96M3.8M2.18M1.57M----250.12M
Issuance (Repayment) of Debt Securities30M60M30M-------
Increase (Decrease) in Bank & Other Borrowings------0.31M----
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities--0.01M--------
Net Cash from (used by) Financing Activities
33.43M65.94M33.8M2.18M1.57M----250.12M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-11.11M7.78M13.19M-27.08M-14.54M-54.14M-39.91M-55.48M-31.7M45.68M
Cash & Equivalents at Beginning of Year63.61M117.76M72.08M124.29M54.83M10.85M1.4M---
Cash & Equivalents at Year End62.59M71.4M76.81M36.53M49.07M63.61M77.84M62.28M86.05M117.76M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Foundation Medicine stock price history provides insight into historical stock price fluctuations, and Foundation Medicine stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Foundation Medicine had a Net Change in Cash and Cash Equivalents of $-11.11M in the latest quarter 2018 Q1. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Foundation Medicine stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Foundation Medicine decreased its cash from operating activities to $-38.89M till 2018 Q1. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-5.68M for FMI till last quarter 2018 Q1 report.
  • Cash flow from financing activities shows the flow of cash between Foundation Medicine and its owners and creditors and was $33.43M till 2018 Q1. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Foundation Medicine Cash Flow

Quarterly Cash Flow Statements For Foundation Medicine Inc Peers

Athenahealth cash flow, Illumina cash flow, Medidata cash flow, OncoCyte cash flow